Abstract: A miniature device enabling parallel in vivo detection of the neurotransmitter choline in multiple brain regions of freely behaving rodents is presented. This is achieved by combining a biosensor microprobe array with a custom-developed CMOS chip. Each silicon microprobe comprises multiple platinum electrodes that are coated with an enzymatic membrane and a permselective layer for selective detection of choline. The biosensors, based on the principle of amperometric detection, exhibit a sensitivity of 157 ± 35 µA mM -1 cm -2 , a limit of detection of below 1 µM, and a response time in the range of 1 s. With on-chip digitalization and multiplexing, parallel recordings can be performed at a high signal-to-noise ratio with minimal space requirements and with substantial reduction of external signal interference. The layout of the integrated circuitry allows for versatile configuration of the current range and can, therefore, also be used for functionalization of the electrodes before use. The result is a compact, highly integrated system, very convenient for on-site measurements.
Introduction
With the continuous growth of worldwide neuroscience research activities, a trend toward addressing more difficult biological questions can be observed [7, 20] . This is, on the one hand, a consequence of the highly complex nature of the central nervous system and, on the other hand, due to the availability of more advanced technology and fabrication processes, especially in microtechnology. Miniature tools for direct interaction with neuronal cells and tissue at single-cell and subcellular length scales become more and more pervasive [21, 34, 40] .
Although wire microelectrodes with a single recording site at the tip still may constitute the dominant experimental method for electrophysiological recordings [11] , several groups start to employ microfabricated probe technology, in which multiple microelectrodes can be integrated on a single probe shank that then access multiple brain sites in parallel at relatively low tissue damage [5, 9, 14, 17, 30] . Arrays of such microprobes and electrodes can be precisely arranged in two or three dimensions, enabling a spatially highly resolved mapping of in vivo neural circuitry and interpretation of network-related phenomena [1, 2, 8, 23, 26, 32] . Multisite recordings have also been performed with wire arrays; however, their assembly is, in most cases, limited in precision and number of electrodes, as they are assembled manually [37, 41] . In brain tissue, neurochemically active molecules are central for intercellular communication, and their monitoring is highly important for understanding brain functions and their relevance with respect to neural diseases such as epilepsy, Alzheimer's disease, and Parkinson's disease [15] . The neurotransmitter acetylcholine, for example, is highly involved in cognitive processing and attention in the central nervous system. It is important for synaptic plasticity and is associated with a variety of behavioral aspects, such as motivation and reward [12, 13] .
Biosensors offer the possibility to monitor several neurotransmitters at suitable temporal resolution. Choline, the breakdown product of freshly released acetylcholine, can be detected via the enzyme choline oxidase, which catalyzes the oxidation of choline to betaine and hydrogen peroxide (H 2 O 2 ). H 2 O 2 , in turn, can be electrochemically oxidized at the surface of a platinum (Pt) electrode, providing a current that is directly proportional to the choline concentration. Good spatial resolution can be achieved by direct immobilization of the used enzymes on top of the microelectrodes.
Several groups have presented such biosensors in the past years. Many of these sensors are based on insulated Pt wires or carbon fibers that are exposed at the tip to create a disc or cylinder microelectrode [19, 24, 27, 28, 31, 35, 38] . Enzyme coating is either performed by dip coating [19, 24, 27] or by dispensing small amounts of enzyme solution over the active electrode area [31, 38] . Furthermore, electrochemical deposition methods with a variety of polymers have been used [28, 35] . They allow for better spatial control, and tedious serial deposition of several electrodes has been replaced by a parallel coating of only targeted and biased electrodes.
Recently, enzyme electrodes have also been integrated on microfabricated probes carrying multiple electrodes [5, 6, 25, 39] . The utilized functionalization methods are similar to previously used single-electrode functionalization methods (drop/dip coating) and are thus limited in upscaling to larger multielectrode ensembles.
Looking at the technological developments, the applications under investigation, and the requests of the neuroscience community, two trends become evident: (a) Use of arrays of implantable biosensors for monitoring of neurotransmitters in different brain areas in parallel (b) Conduction of trials and recordings in freely behaving, task-performing animals in order to correlate concentration variations of specific neurotransmitters to observable behavior.
Both trends entail stringent technology requirements [4] . Precise fabrication of microelectrode arrays is crucial for accurate positioning and definition of the inter-electrode spacing. Reliable functionalization protocols for multiple microelectrodes to create biosensor arrays have to be developed, as well as electrochemical setups capable of acquiring many signals in parallel featuring the needed performance and reliability. Array compatibility of the microelectrode fabrication and biosensor functionalization procedures, as well as multiple signal acquisition, are mandatory prerequisites. Furthermore, noise reduction techniques to enable low analyte detection limits and small overall device dimensions in order to not impede the animal during experiments are important issues.
We recently developed a biosensor microprobe array [17] , based on silicon microfabrication, and the corresponding array-compatible electrode functionalization techniques through electrochemical methods. Our next step included combining this array with a CMOS Figure 1 Layout of the microprobe comb consisting of four identical shanks of 6.5 mm length, each comprising two recessed 50 μm × 150 μm working electrodes (zoomed view) and one 40 μm × 500 μm electrode, used either as reference or counter electrode. Cross-sections AA′ and BB′ show the layer structures at the recessed electrode and pad site, respectively.
(complementary metal oxide semiconductor) chip that has been developed in our laboratory and that hosts circuitry for performing electrochemical experiments, as well as on-chip analog-to-digital conversion. With the overall system packaged in a compact and flexible way, it can be mounted directly on a rodent's head and features a minimum of cable connections even for many electrodes due to on-chip integrated multiplexing circuitry. This technological approach constitutes a step toward threedimensional neurochemical mapping of local brain areas.
Materials and methods

Silicon microprobes
The microprobe array has a comblike design, consisting of four parallel, identical shanks at 550 µm pitch, featuring a length of 6.5 mm and a cross-sectional area of 40 µm × 100 µm ( Figure 1 ). Each shank comprises two Pt microelectrodes, located at 500 µm distance from the tip and featuring an area of 50 µm × 150 µm. Both electrodes are recessed by 10 µm in order to create a small compartment that protects the biosensitive membrane during tissue insertion and removal. The distance between the electrodes is 200 µm. On each shank, a larger, 40 µm × 500 µm, non-recessed electrode, located in the middle of the shank, can be used either as pseudo-reference or a counter electrode. When used as a reference electrode, the Pt layer is electrochemically covered with a 5-µm-thick silver layer that is partially transformed into AgCl. The present geometry of the comb has been chosen to target the medial prefrontal cortex of a rat's brain.
The microprobe arrays have been fabricated using standard micromachining techniques on 4-in., 300-µm-thick silicon wafers. Potassium hydroxide (KOH) wet etching has been used to create the recesses of the working electrodes. This has the advantage that the interconnection lines can be laid across the inclined side walls appearing during the KOH etch. The substrate is insulated (bottom passivation) with, first, a 200-nm-thick layer of thermal silicon oxide and, second, by a deposition of 200 nm of low-pressure chemical vapor deposited (LPCVD) silicon nitride. A 130-nm Pt with a 20-nm tantalum adhesion layer has been deposited by using e-beam evaporation and structured by means of a lift-off process. The top passivation consists of 200-nm LPCVD silicon nitride that has been removed at the electrode and contact pad sites through reactive ion etching to expose the underlying Pt. The microprobe has been shaped with two deep reactiveion etching steps. First, the wafer has been thinned from the backside to the intended shank thickness (40 µm). Second, the contours of the microprobes have been etched from the front side, which released them from the bulk. Small joints are retaining the microprobe combs in the wafer grid, where they are stored and can then be released immediately before use (for further details and figures of each individual step, refer to ref. [17] ).
CMOS chip
The schematic of the device and its electrochemical principle are depicted in Figure 2 . An external master potentiostat controls the voltage difference between the reference electrode and all working electrodes. The electrochemically generated current on each individual working electrode is measured in parallel using CMOS integrated circuitry.
The CMOS chip has been fabricated in an industrial 0.6-µm, 5-V 3M2P CMOS process (X-FAB, Erfurt, Germany) and has been previously presented in detail [22, 29] . It comprises 24 current read-out channels, eight of which are used for the microprobe comb to simultaneously record from the eight integrated working electrodes. The current measurement scheme is based on a very compact sigmadelta converter. It makes use of the double-layer capacitance of the electrode-electrolyte interface to integrate the charge. The potential of the electrode is kept at a certain voltage by adding or subtracting charge from the doublelayer capacitance with the precharged reference capacitor C Ref . The amount of charge that is delivered per time is the current that flows through the working electrode.
The converter circuit features very low noise, and the full-scale current range, I FS , can be set by changing the sampling frequency, f s , the reference capacitance, C Ref , and the reference voltage, V Ref , which is used to charge C Ref : The large adjustable range, I FS , allows, on the one hand, for recording of very low currents in the measurement mode, and, on the other hand, for application of large currents for electrochemical depositions on the electrodes.
Device packaging and setup
A custom-designed printed circuit board (PCB) hosts a CMOS chip, a microprobe comb, and additional electrical components for the master potentiostat. The PCB has a flexible front part allowing for vertical implantation of the microprobe comb into the brain and flat positioning and fixation of the electronic part on the animal's skull by using dental acrylic glue and fixation bolts. This results in a compact assembly on the animal's head with minimal disturbance for the animal while performing the experimental task. The CMOS chip is glued on the top of the PCB and wire bonded. On the bottom, two operational amplifiers (AD8539, Analog Devices, Norwood, MA, USA), two resistors (1 MΩ), and two capacitors (100 nF, 10 µF) for electrical decoupling form the master potentiostat, which holds the bulk at a defined potential controlled by the reference electrode. All parts are encapsulated in non-transparent epoxy glue for electrical and mechanical protection. On the backend of the device, a zero-insertion-force connector can be connected for electronic control and data acquisition. V Set defines the potential difference between the reference electrode and all working electrodes.
A thin, flexible cable is used to connect the device to a field-programmable gate array (FPGA) module for chip control and data processing (Figure 3 ). The FPGA performs filtering and decimating of the output signals of the sigma-delta modulators to yield high-resolution signals. Therefore, two filters have been implemented, a cascaded integrator-comb filter, used as a first filter stage, and an exponential moving average filter as a second stage. The FPGA is connected via USB to a conventional laptop running Labview that records the measurement data and supplies power to the system.
Electrode functionalization
The biosensor principle is based on amperometric detection of peroxide using an enzymatic membrane, deposited on a Pt microelectrode. For the detection of choline, the enzyme choline oxidase from Alcaligenes sp. (ChoOx, EC 1.1.3.17) has been used and immobilized on the Pt surface by electrochemically aided adsorption. Briefly, the whole array has been immersed into a freshly mixed deposition solution comprising the enzyme, the protein albumin from bovine serum (BSA), and the cross-linker glutaraldehyde (all from Sigma Aldrich, Switzerland). The application of a sequence of electrical potentials (25 times 1.8 V vs. Ag/AgCl) increases the protein concentration at the biased electrode, which initiates a local cross-linking and the formation of gelatinous membrane containing ChoOx. The detailed deposition protocols have already been described elsewhere [17] . Here, they have been applied without any external potentiostat but by directly using the integrated circuitry. Owing to the high deposition potential used, the current range of the sigma-delta converters has been set to I FS = ± 58.9 µA (C Ref = 10 pF, V Ref = ± 1.9 V, f s = 3.1 MHz). For the deposition, an external Pt wire and Ag/AgCl wire have been used for the counter and reference electrodes, respectively. The adhesion of the membrane to the electrode surface has been improved by a coating of (3-aminopropyl)triethoxysilane (Sigma) via vapor silanization before deposition.
Subsequently, m-polyphenylenediamine (m-PPD, Sigma) has been electropolymerized on the microelectrodes by cyclic voltammetry (20 cycles, 0-0.9 V vs. Ag/AgCl, 50 mV/s) and used as permselective layer to substantially reduce interference signals from other electroactive species such as dopamine (DA) and ascorbic acid (AA). Also present in the extracellular fluid of the brain, they are oxidized at a similar potential as used for the As both deposition procedures rely on electrochemical principles, they can be spatially controlled and can be executed in parallel on multiple electrodes of the array. In general, the microelectrodes closer to the tip (xf in Figure  4 ) on each shank are coated with an enzyme membrane. On the adjacent electrodes (xb), an "inactive" BSA-protein-only membrane is deposited. The latter is used as a control or "null" sensor in a differential measurement mode. The protein membrane is required to match the diffusion properties of the sensitive microelectrodes.
After functionalization, the devices are stored dry at 4°C.
Electrochemical recording setup
Calibration measurements have been conducted in 50 ml phosphate-buffered saline solution at either 37°C or room temperature (22-25°C). The liquid has been continuously stirred using a standard magnetic stirrer. No Faraday cage was used. Small volumes of choline, DA, and AA stock solutions have been added manually at constant time intervals to obtain defined analyte concentrations. It has been assumed that homogenous dissolution is achieved in less than a second. All eight working electrodes have been polarized at 0.65 V using the probe-integrated thin film Ag/AgCl reference and Pt counter electrodes. The current range has been set to I FS = ± 2.5 nA (C Ref 
Recordings in agarose gel (1%) have been performed at room temperature with the same electrochemical settings. The biosensor electrodes have been placed 5 mm below the surface using a micromanipulator. The tip of a glass micropipette filled with 200 µM colored choline solution has been positioned at a distance of ~300 µm from electrode 4a (see top view in Figure 7 ) by using a second micromanipulator. Collinear insertion and slow injection rates ( < 100 nl/min) are important to avoid cracks in the gel, which would lead to inhomogeneous, non-spherical choline diffusion.
Results and discussion
Device characteristics and functionality
The used microfabrication processes allowed for precise and reproducible fabrication of the microprobe arrays with ± 2 µm accuracy with respect to the designed masks. Straight and smooth shanks with a very sharp tip reduce tissue damage and brain surface deformation during implantation (see Figure 4 and ref. [17] ). The same process can be used for future layouts that are different in shank number and length, as well as in the number and position of the microelectrodes on each shank, and targeted at specific brain regions in different experimental setups. Besides such rigid microprobes, other groups have presented flexible constructs that may better match the mechanical properties of the soft brain tissue [10, 33, 36] . Sufficient long-term biocompatibility has been observed; however, precise electrode positioning may be more difficult.
The quality of the Pt electrodes has been assessed electrochemically. Figure 5 shows an overlay of 10 consecutively recorded cyclic voltammograms (CVs) of all eight microelectrodes. All CVs have been recorded in parallel in 1 M de-aerated H 2 SO 4 in the potential window of -0.42 to 1.20 V versus the shank-integrated Ag/AgCl reference electrode at 100 mV/s. Adequate Pt electrode quality and reproducibility is demonstrated, and a high current/ voltage resolution of the CMOS circuitry is evident, as clearly resolved single peaks in the hydrogen region are visible on all eight electrodes. The roughness factor (effective surface/geometric surface) of the Pt electrode is 1.1 (8200 µm 2 /7500 µm 2 ) and compares well to previous publications [16, 17] . It has been calculated by the measured charge associated with a 100% hydrogen coverage, which corresponds to the positive region between -0.42 to 0.00 V (shaded area A C in Figure 5 ) upon assuming 210 µC/cm 2 charge transfer [3] . CVs have been measured before every microelectrode functionalization for the purpose of electrochemical cleaning of the electrodes and for controlling the Pt quality, to check on inter-electrode cross-talk and to assess the general electrical functionality of each channel.
The CMOS chip has a power consumption of 25 ± 5 mW. Its small size of 6.5 mm × 3.0 mm allows for construction of a small head stage, suitable for freely behaving animals. More important, electrochemical signals of many electrodes are digitized on-chip, making it less susceptible to external interferences such as electromagnetic fields or cable distortions. Linearity and electrical noise within the smallest current range allow for resolving currents below 0.5 pA. While the use of CMOS technology allowed for a substantial miniaturization of the signal acquisition part, the overall size reduction of the head stage is, currently, on the one hand, limited by the PCB that is required to connect to the CMOS chip via wire bonds and, on the other hand, by the size of the cable connector, which has to be robust and reliable during experiments. The whole setup including the FPGA module and laptop is very compact and therefore very convenient for field experiments. Figure 4 shows a photograph of the eight coated microelectrodes. Membranes of the same type (enzyme vs. BSA membranes) have been deposited in parallel. The picture shows identical and spatially well-controlled depositions on all electrodes with minimal unspecific adsorption on the shank. The larger electrodes in the middle of shanks 1 and 2 have been used as integrated Ag/AgCl reference electrodes. The Ag/AgCl layer nicely covers the underlying Pt. A potential of +68.4 ± 0.8 mV (n = 6) versus a standard liquid-phase Ag/AgCl reference electrode (3 M KCl) was reproducibly measured in PBS (pH 7.2).
Biosensing characteristics and application
Raw data of simultaneously recorded in vitro current response curves of a calibration measurement of all choline biosensors are presented in Figure 6A . The electrodes have been functionalized as depicted in Figure 4 . The measurement was performed 1 day after membrane deposition. For better visibility, the single recorded curves have been offset. "xf" and "xb" denote the signals of the active and inactive electrodes, respectively. "xf-xb" shows the differential curves, with the inactive electrode signals being subtracted. The biosensors show good reproducibility of all electrodes with respect to sensitivity and selectivity. Active biosensor electrodes instantaneously respond to 10 µM choline injections, which correspond to concentrations expected in the extracellular fluid of a rat brain. The sensitivity was determined to be 11.8 ± 2.6 pA/µM, corresponding to 157 ± 35 µA mM -1 cm -2 (n = 35) with a linear range up to 100 µM ( Figure 6B ). The standard deviation reflects the sensitivity variation obtained by using biosensors of different deposition runs and different fabrication batches. The m-PPD layer efficiently blocks DA and AA. The choline signal is not altered owing to the presence of DA and AA in the PBS solution. In some cases, a small increase in current is visible for DA or AA on the active electrode (xf). When diffusion and rejection properties are comparable for both electrodes, a similar contribution is also observed on xb and can be effectively removed by using the differential method (xf-xb). The rejection characteristics of xf and xb, however, are not always the same, but have to be adjusted by proportional scaling of the signals on the basis of the differences in the recorded calibration curves. If the difference between corresponding electrodes, xf and xb, is > 20%, biosensors are not used. Owing to the parallel nature of the deposition process, the inter-electrode variability of the response to choline is as low as 6.9 ± 4.6% (n = 10, with n being the number of microprobe arrays), which represents the relative standard deviation calculated from the standard deviations of the sensitivities of the four biosensors of each of the 10 microprobe arrays. Thus, biosensor sensitivities within a device vary by 7% on average. In some cases, we observed a small cross-talk ( < 5%) between adjacent electrodes (xf and xb). As this cross-talk was not consistent, we assume the reasons to be cross-contamination during deposition or electrical cross-talk. The temperature dependence was measured to be 0.3 ( = 2.75%) pA µM -1 °C -1 (n = 4). The differential method significantly reduces the noise level to < 1 pA (peak-to-peak) in PBS, and to 3 pA at a choline concentration of 20 µM ( Figure 6C ). This results in a limit of detection of 0.25 and 0.8 µM, respectively (three times the background). It has to be mentioned here that the experiment was carried out on a conventional laboratory bench without Faraday cage. Neither magnetic stirring nor different manipulations of the experimenter influenced the noise level, demonstrating the benefit of the circuitry integration. Figure 6D shows the fast response time of the biosensor, which is on the order of 1 s. However, it is highly dependent on the method used for changing the choline concentration in the solution and may be even smaller when using a flow injection system. Further characteristics, such as biosensor shelf lifetime and interference rejection rates over time, can be found in refs. [17, 18] .
One micromolar of peroxide produced a current signal of 24.9 pA (not shown in the graph). Considering that ChoOx produces two molecules of H 2 O 2 per choline molecule, an efficiency of about 20% can be calculated, which gives an indication on the enzyme load and electro-oxidation efficiency of H 2 O 2 . It further shows that the ChoOx-mPPD membrane has a good H 2 O 2 permeability.
The usability of such a multielectrode configuration is illustrated in Figure 7A . Colored choline solution (200 nl) has been injected in the vicinity of the fourth shank, inserted in agarose gel (1%), which has been used here as a brain-mimicking substrate. While the expected spherical diffusion can be observed optically, the four biosensors are responding according to their location relative to the injection site. Figure 7B shows the derived concentration distributions at t i [s] = t 0 +i × 100 s for i = {1,…,7}. 
Conclusion
The presented device is based on microelectrode fabrication and dedicated electrode functionalization so that truly simultaneous multisite neurochemical recording in freely behaving animals becomes possible. It has been realized by combining silicon-micromachined multishank probes with a versatile CMOS chip offering electrochemical functionality.
Silicon microfabrication technologies allow for precise and custom-designed fabrication of microprobes of almost any desired shape and number, which can be equipped with multiple microelectrodes. Functionalization of these microelectrodes requires a reproducible and array-compatible method, i.e., a method that can be spatially controlled and is preferably parallel. Therefore, electrochemistry-based methods have been used for electrode cleaning, enzyme immobilization, and deposition of the anti-interference layer. The electrochemical protocols have been executed directly with the CMOS circuitry and do not require any additional equipment. This has become possible by the implementation of adjustable current ranges of the CMOS sigma-delta converters.
The key advantage of the chip integration is the digitalization of the measured signals in immediate vicinity to the sensors. Given the favorable characteristics of the biosensors with regard to sensitivity, selectivity, detection limit, and response time, the system enables parallel amperometric measurements at a very good signal-tonoise ratio, whereas no additional noise contributions are picked up through connecting leads. This is crucial for reliable measurements in non-ideal environments with, e.g., freely moving animals. Multiplexing of the signals of the different channels helps reduce the number of connections and helps minimize the dimensions of the flexible cable between the animal head stage and the control module. Integration of the potentiostat on chip for purely digital wire communication as well as wireless transmission may be envisaged in future generations of the chip.
Finally, the compact control and acquisition module is very convenient for on-site recordings and integration into experimental setups. The devices are currently optimized and tested with freely moving rats showing impulsive behavior performing the five-choice serial reaction time task. In semi-acute experiments, the devices have been implanted for recordings up to 2 weeks. The relatively short experimentation time is limited by the stability of the enzyme in vivo, which defines the functional lifetime of the device. In vivo stability of the sensor and the microprobe as well as biocompatibility and the anticipated time span of use are important features to be addressed in the near future. Figure 7 Recorded responses from four electrodes (A) and derived concentration profile at different time points (B) after a choline solution has been injected at a distance of 300 µm from biosensor electrode 4f (see Figure 4) . The insert in (A) shows the geometric layout of injection point and electrode locations.
